Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Patients with Cirrhosis and Healthy Volunteers Show Comparable Characteristics.,International Journal of Stem Cells

当前位置： X-MOL 学术 › Int. J. Stem Cells › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Patients with Cirrhosis and Healthy Volunteers Show Comparable Characteristics.
International Journal of Stem Cells ( IF 2.3 ) Pub Date : 2020-08-31 , DOI: 10.15283/ijsc20072
Yoo Li Lim ₁ , Young Woo Eom _{2,

3} , Su Jung Park _{3,

4} , Taeui Hong _{3,

4} , Seong Hee Kang _{1,

3,

4} , Soon Koo Baik _{1,

3,

4} , Kyu-Sang Park _{4,

5} , Moon Young Kim _{1,

3,

4}

Affiliation

Autologous or allogeneic bone marrow-derived mesenchymal stem cells (BMSCs) have been applied in clinical trials to treat liver disease. However, only a few studies are comparing the characteristics of autologous MSCs from patients and allogeneic MSCs from normal subjects.

中文翻译：